Evidence map›Paper›PMID 28380432›Full record

ArticleOncotarget2017

Patients with uterine leiomyoma exhibit a high incidence but low mortality rate for breast cancer.

Te-Chun Shen, Te-Chun Hsia, Chieh-Lun Hsiao, Cheng-Li Lin, Chih-Yi Yang, Khay-Seng Soh, Liang-Chih Liu, Wen-Shin Chang, Chia-Wen Tsai, Da-Tian Bau

Abstract readComparative Study
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Association of Fibroids, Endometriosis, and Gynecologic Surgeries with Breast Cancer Incidence and Hormone Receptor Subtypes.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Te-Chun ShenGraduate Institute of Clinical Medical Science, College of Medicine, China Medical University, Taichung, Taiwan.
Te-Chun HsiaGraduate Institute of Clinical Medical Science, College of Medicine, China Medical University, Taichung, Taiwan.
Chieh-Lun HsiaoTerry Fox Cancer Research Laboratory, China Medical University Hospital, Taichung, Taiwan.
Cheng-Li LinManagement Office for Health Data, China Medical University Hospital, Taichung, Taiwan.
Chih-Yi YangDepartment of Obstetrics and Gynecology, China Medical University Hospital, Taichung, Taiwan.
Khay-Seng SohDepartment of Breast Surgery, China Medical University Hospital, Taichung, Taiwan.
Liang-Chih LiuDepartment of Breast Surgery, China Medical University Hospital, Taichung, Taiwan.
Wen-Shin ChangTerry Fox Cancer Research Laboratory, China Medical University Hospital, Taichung, Taiwan.
Chia-Wen TsaiTerry Fox Cancer Research Laboratory, China Medical University Hospital, Taichung, Taiwan.
Da-Tian BauGraduate Institute of Clinical Medical Science, College of Medicine, China Medical University, Taichung, Taiwan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The association of uterine leiomyoma with increased risk of breast cancer is controversial. Therefore, we used the National Health Insurance Research Database of Taiwan to examine breast cancer incidence and mortality among Asian patients with and without uterine leiomyoma. We compared breast cancer incidence and mortality between 22,001 newly diagnosed uterine leiomyoma patients and 85,356 individuals without uterine leiomyoma matched by age and date of diagnosis. Adjusted hazard ratios for breast cancer were estimated using the Cox model. The incidence of breast cancer was 35% higher in the uterine leiomyoma group than the leiomyoma-free group (1.65 vs. 1.22 per 1,000 individuals, p < 0.001), with an adjusted hazard ratio of 1.31 (95% confidence interval = 1.13-1.52). Interestingly, overall mortality was lower (4.12%) in the uterine leiomyoma group (mean followed time, 3.59 ± 2.70 years) than the leiomyoma-free group (8.78%; mean followed time, 3.54 ± 2.67 years) at the endpoint of the study (p <0.05). These findings indicate the incidence of breast cancer is higher in patients with uterine leiomyoma than in those without it, but overall mortality from breast cancer was lower in the patients with uterine leiomyoma.

Indexed as

AdultBreast NeoplasmsFemaleHumansIncidenceLeiomyomaMiddle AgedMortalityProportional Hazards ModelsTaiwanUterine NeoplasmsYoung Adultbreast cancercohort studyuterine leiomyoma

Identifiers

PMID28380432
PMCPMC5464846

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.